Vitamin B12 Benefits and Deficiency: What’s Actually at Stake

Vitamin B12 deficiency is far more common than most people realize, and its consequences are far more serious than the supplement industry’s marketing suggests. This is not a minor fatigue issue correctable with a gummy vitamin. Severe B12 deficiency causes irreversible neurological damage, megaloblastic anemia, and elevated cardiovascular risk markers that take years to develop and longer to resolve. The challenge is that deficiency develops slowly and its symptoms are attributed to other causes for years before the connection is made. This guide covers who is at risk, what deficiency actually looks like, how the lab testing trips up most clinicians, and how it is addressed clinically when caught.

Vitamin B12 Benefits: What It Does in the Body

Vitamin B12 (cobalamin) is required for three critical biochemical processes, and impairment of any one of them produces clinical symptoms even before the others become obvious.

DNA synthesis and cell division. B12 acts as a cofactor for methionine synthase, an enzyme essential for the methylation reactions that support DNA replication. Deficiency impairs cell production most visibly in rapidly dividing cell lines: red blood cells, intestinal epithelium, and the cells lining the mouth and tongue. This is why glossitis (smooth, swollen, inflamed tongue) is sometimes the earliest visible sign of B12 deficiency, and why some patients notice GI symptoms or mouth changes before the more classic anemia or neurological signs.

Red blood cell formation. Without B12, red blood cell precursors cannot divide properly, producing fewer red blood cells that are larger and abnormally shaped. This pattern is megaloblastic anemia: red blood cells too large to function efficiently, producing the fatigue, weakness, pallor, and reduced exercise capacity that lead patients to seek evaluation in the first place. The mean corpuscular volume (MCV) on a standard CBC is the easiest signal of this pattern, with values above 100 fL flagging the possibility of B12 or folate deficiency.

Myelin synthesis and neurological function. B12 is required for the production and maintenance of myelin, the insulating sheath around nerve fibers that allows fast and reliable nerve conduction. Deficiency causes progressive demyelination, producing the neurological symptoms that distinguish B12 deficiency from other anemias: numbness and tingling in the hands and feet, balance problems, cognitive decline, and in severe untreated cases, irreversible spinal cord damage in a pattern called subacute combined degeneration. The neurological symptoms can develop and persist even when the anemia is mild or absent, which is one reason B12 deficiency is missed when clinicians focus only on the CBC and not on the clinical picture.

Who Is at Highest Risk for Vitamin B12 Deficiency

Several specific patient groups carry meaningfully elevated risk that justifies routine screening rather than waiting for symptoms.

Patients on metformin. Metformin is one of the most commonly prescribed medications worldwide and is used at Tactus Health as part of certain weight loss and metabolic protocols. It impairs B12 absorption in the terminal ileum through a mechanism involving calcium-dependent transport. A PubMed study of long-term metformin use and B12 documented that up to 30 percent of long-term metformin users develop B12 deficiency, and the risk increases with both dose and duration of therapy. Annual B12 monitoring is standard for any patient on metformin, and oral repletion is often inadequate because the absorption pathway itself is the problem.

Patients on proton pump inhibitors. PPIs reduce stomach acid, which is required to cleave B12 from food protein in the first step of absorption. Long-term PPI use significantly increases B12 deficiency risk, particularly in patients over 60. The FDA safety communication on long-term PPI use highlighted the cumulative concerns of extended PPI therapy, with B12 monitoring and bone density attention among the practical issues that require clinical follow-up.

Patients over 50. Atrophic gastritis, a common age-related change in stomach lining, reduces intrinsic factor production. Intrinsic factor is the protein required for B12 absorption in the terminal ileum, and reduced production means reduced B12 uptake regardless of dietary intake. Prevalence increases with age, affecting roughly 10 to 30 percent of adults over 50 to varying degrees, with higher prevalence in patients with autoimmune conditions affecting parietal cells.

Vegetarians and vegans. B12 is found almost exclusively in animal-derived foods. Plant-based eaters who do not supplement reliably are at significant risk, and the slow timeline of B12 storage depletion means deficiency can develop several years after dietary change before becoming clinically obvious. Fortified foods help but do not always provide enough to maintain status without supplementation.

GLP-1 patients with significantly reduced food intake. Patients on semaglutide or tirzepatide who are eating very little are at risk for multiple micronutrient deficiencies including B12, particularly during the dose-escalation phase. The slowed gastric emptying that contributes to GLP-1 efficacy also reduces the time available for B12 release from food protein, compounding the dietary intake reduction.

Symptoms That Are Often Missed

The reason B12 deficiency goes undiagnosed for years is that the symptom pattern is nonspecific and the classic textbook presentation (severe anemia, glossitis, ataxia) is the late-stage version. Earlier symptoms get attributed to stress, aging, or unrelated conditions, and the diagnostic possibility is not raised until the picture becomes obvious.

Common early-to-moderate symptoms include fatigue and weakness that patients describe as different from normal tiredness, often a heavy or leaden quality rather than simple sleepiness. Numbness or tingling in the hands and feet (peripheral neuropathy) is one of the most specific symptoms and the one most likely to be ignored because it can feel minor. Balance problems and coordination difficulty develop gradually. Cognitive changes including memory lapses, difficulty concentrating, and slowed thinking are common but often attributed to age, stress, or perimenopausal hormone changes. Mood changes, including depression and irritability, are common enough that B12 status is worth checking in any new mood presentation.

Less common but more specific signs include glossitis (smooth, swollen, inflamed tongue), pale or jaundiced skin, and elevated homocysteine levels on labs. Homocysteine is a cardiovascular risk marker regulated by B12 and folate, and elevation can flag deficiency before serum B12 levels fully reflect the problem.

Injectable vs Oral B12: When Each Is Appropriate

For patients whose deficiency is driven by absorption impairment (intrinsic factor deficiency, PPI use, metformin, post-bariatric surgery), oral B12 supplementation is only partially effective because the absorption mechanism itself is what is compromised. High-dose oral B12 can produce some absorption through passive diffusion, but the response is unpredictable and slower than injection routes can achieve.

Intramuscular or subcutaneous B12 injections bypass the gut entirely and reliably restore levels regardless of the underlying absorption problem. The standard injectable form is cyanocobalamin or methylcobalamin, with methylcobalamin being the methylated active form preferred by some clinicians though the clinical difference is modest in most patients. Injection schedules vary by indication: weekly for acute repletion of significant deficiency, then monthly or every 3 months for maintenance once levels normalize. Patients with chronic absorption issues (post-bariatric surgery, pernicious anemia) typically remain on indefinite scheduled injections.

Tactus Health offers Lipo-B injections containing B12 alongside other B vitamins and lipotropic agents as part of the wellness program. For patients with documented isolated B12 deficiency where the lipotropic component is not specifically indicated, standalone B12 injections are also available. The choice between the two formulations depends on the broader clinical picture rather than on a one-size protocol.

Common Patient Questions

Should I just take a B12 supplement to be safe? Healthy adults with normal absorption can usually maintain status through diet plus a basic multivitamin. Supplementation rarely causes harm at standard doses (B12 has no known toxicity), but supplementation alone cannot replace the workup in patients with symptoms or risk factors. The right approach is to confirm whether deficiency is present and whether absorption is the issue, then choose the supplementation route that fits the picture.

How long does it take to feel better after starting injections? Energy and fatigue improvements often appear within 1 to 2 weeks of starting weekly injections. Cognitive and mood improvements typically take 4 to 8 weeks of consistent treatment. Neurological symptoms (numbness, tingling, balance) can take 6 to 12 months to resolve and may not fully reverse if deficiency was severe and prolonged before treatment, which is why catching it earlier matters.

Can I have too much B12? Standard doses of B12 from supplements or injections do not produce toxicity in healthy people. The body excretes excess B12 through the kidneys. Very high single doses occasionally produce mild acne flares or vivid dreams in some patients, but these are not clinically significant.

Are sublingual B12 lozenges effective? They can be, particularly in patients without significant absorption impairment. Sublingual delivery bypasses the gastric acid and intrinsic factor pathway, which is why they sometimes work where standard oral supplements do not. They are generally not as reliable as injection in patients with significant deficiency.

What labs should I get to evaluate B12 status? Serum B12 is the starting point, but methylmalonic acid (MMA) and homocysteine are the more sensitive markers when serum B12 is borderline. CBC for MCV is useful to flag the megaloblastic pattern. For patients with symptoms suggesting absorption problems, intrinsic factor antibodies and parietal cell antibodies can identify autoimmune pernicious anemia.

The Bottom Line

B12 deficiency is common, often missed, and capable of causing irreversible damage if undiagnosed long enough. The highest-risk groups (metformin users, PPI users, adults over 50, vegetarians and vegans, GLP-1 patients) deserve routine screening rather than waiting for symptoms. The lab evaluation works better when it includes methylmalonic acid and homocysteine alongside serum B12, particularly when the serum value is borderline. Treatment is straightforward when caught: injectable B12 reliably restores status regardless of absorption capacity, and the clinical response is predictable and rewarding. The harder problem is the diagnostic step, which is why screening matters more than supplementation does.

Medically Reviewed By

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Co-Founder & Medical Director at Tactus Health. Dual board-certified, with clinical focus on wellness, hormone optimization, and medical weight loss. Sugar Hill, GA and telehealth for Georgia patients.